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The Laterjet-Duplan strain of radiation murine leukemia virus (MuLV) l differs 
from most other virus isolates in that it induces nonthymic rather than thymic 
lymphomas in mice (1).  Haas and co-workers (2,  3) demonstrated that cell-free 
extracts produced from "reticulum cell neoplasms" (RCN) of mice infected with 
this  agent contained a  mixture of ecotropic, xenotropic, and  mink cell  focus 
(MCF)-inducing (4) MuLV. A cell line derived from bone marrow, termed RCN- 
BM5,  has  served  as  a  source  of these  viruses  in  subsequent  studies,  which 
suggested that the lymphomagenic component in the virus mixture was an MCF- 
inducing MuLV (3, 5). Young adult mice infected with phenotypic mixtures of 
a  nonpathogenic ecotropic virus and the MCF virus rapidly developed lymph- 
adenopathy and splenomegaly, and died with massive enlargement of these tissues 
(2, 3, 5). 
Although initial histologic studies of tissues from virus-infected mice yielded 
the diagnosis of RCN type B (2), according to Dunn's (6) classification of murine 
hematopoietic  tumors,  later  studies  (5)  indicated  that  the  mice  developed  a 
polycional proliferation of B cells that may not be truly malignant. The splenic 
and nodal lesions, while classified as polyclonal immunoblastic B cell lymphomas, 
could not be transplanted, contained diploid cells throughout the course of the 
disease, and were rarely invasive of nonlymphoid tissues. Since, by these criteria, 
the lesions induced by the viruses in  RCN-BM5  are non-neoplastic, the term 
"reticulum cell neoplasm" appears to be inappropriate. To indicate the nonma- 
lignant lymphoproliferative nature of this disease, we will  refer to the MuLV 
mixture from the BM5 tissue culture line as LP (lymphoproliferative)-BM5. 
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The current studies of LP-BM5  MuLV  were initiated  in our laboratories to 
determine the cellular mechanisms responsible for this unusual proliferation and 
polyclonal activation of B ceils. We report here that injection of the virus mixture 
into adult C57BL/6 mice caused a rapid induction of cell proliferation, not only 
of B  lymphocytes, but also of T  lymphocytes and non-T, non-B lymphoid cells. 
All  B  lymphocytes showed  evidence of polyclonal activation,  and  many  were 
actively secreting IgM  or IgG.  There was a  brief period of increased immune 
responsiveness, followed quickly by a  lasting and profound immunosuppression 
that affected all measured aspects of cellular and humoral immunity. The mice 
died 4-6 mo after virus inoculation, and showed massive lymphadenopathy. We 
thus conclude that  the  LP-BM5  MuLV-induced disease  is a  new mouse model 
for the  rapid  induction  of polyclonal  lymphocyte proliferation  and  profound 
immunosuppression by retroviruses, and that the model may have considerable 
relevance for similar retrovirus-induced syndromes in humans. 
Materials and  Methods 
Mice.  C57BL/6NIcr mice of both  sexes were used at  6-12  wk  of age.  Mice were 
reared either at the Laboratory Animal Facility of the Institute for Cancer Research or 
the Small  Animal Section of the Division of Research Resources, National Institutes of 
Health.  All  animals  were caged and  handled  in accord with  the  National  Institute of 
Health Guidelines for the Care and Use of Laboratory Animals (Department of Health 
and Human Services publication 80-23). 
Virus Passage.  Subcultures of the bone marrow stromal cell line described previously 
(2) were obtained from Dr. Martin Haas, University of California at San Diego. This cell 
line  was  maintained  by biweekly subculture  in  Dulbecco's modified minimal  essential 
medium supplemented with 10% fetal bovine serum. Cell-free filtrates were prepared by 
collecting culture medium after 3-4 d of growth, centrifuging the culture fluids at 3,000 
rpm for 10 min, and passing the supernatant through a 0.22 #m Millipore filter. 1 ml of 
the filtered supernatant was injected intraperitoneally into recipient mice within  1 h of 
preparation. These inocula contained 5  ×  103-104  infectious ecotropic as well as MCF 
MuLV. All C57BL/6 mice injected in this way developed evidence of lymphoproliferative 
disease within 3 wk. 
Antigens and Mitogens.  The preparation of trinitrophenyl (TNP)-coupled lipopolysac- 
charide (LPS), Brucella abortus (B. abortus), and aminoethylcarbamylmethyI-Ficoll (Ficoll) 
have been described previously (7). Sheep red blood cells (SRBC) were obtained from a 
single animal (#190) at Colorado Serum Co., Denver, CO.  Phytohemagglutinin (PHA) 
was obtained from Burroughs Wellcome, Beckenham, England, concanavalin A (Con A) 
from Pharmacia Fine Chemicals, Piscataway, NJ, and LPS 011 l:B4 from Difco Labora- 
tories,  Inc.,  Detroit, MI.  The preparation of affinity-purified goat anti-/~ has been de- 
scribed previously (8). 
Media  and  Culture  Conditions.  Most  cultures  of spleen  or  lymph  node  cells  were 
performed at a cell density of 5 ×  105 cells in 0.2 ml RPMI  1640 supplemented with 5% 
fetal  bovine  serum,  15  mM  Hepes,  5  ×  10  -5  M  2-mercaptoethanol,  and  50  #g/ml 
gentamicin. Mitogen responses, mixed lymphocyte reactions (MLR), and plaque forming 
cell (PFC) responses to T-independent antigens were performed in 0.2 ml microcultures 
in 96-well,  flat-bottom trays (model 3596, Costar Packaging Corp., Cambridge, MA). In 
vitro responses to SRBC were performed in  1 ml cultures (3524 trays Costar Packaging 
Corp.) containing 5 ×  106 cells/ml. In selected experiments, B cell survival was followed 
in serum-free Iscove's F12 medium (9). 
Assays.  Proliferation was determined by measuring the incorporation of [3H]thymidine 
into DNA following a 4 h pulse after 3-5 d of culture. Cytotoxic T  lymphocyte (CTL) 
effector cells were generated in mixed lymphocyte cultures, and their activity was quan- 
titated  using  5~Cr-labeled,  concanavalin  A  (Con  A)-stimulated  lymphoblast targets,  as 768  MURINE  RETROVIRUS-INDUCED IMMUNOSUPPRESSION 
described  (10).  PFC assays were performed  using SRBC,  TNP-coupled SRBC (11),  or 
protein A-coupled SRBC (12) as indicator cells.  Assays were done after 3-5 d of culture. 
Rabbit anti-~ serum was used to develop protein A-PFC (12). Serum Ig isotype determi- 
nations were carried out using a  competitive radioimmunoassay (RIA). Briefly, flexible 
polyvinylchloride microtiter tray wells (Dynatech Labs, Alexandria, VA) were coated with 
a  purified hybridoma protein of the appropriate  isotype, diluted in phosphate buffered 
saline (PBS) containing 0.01% bovine serum albumin (BSA). The plates were blocked by 
the addition  of 1%  BSA in  PBS, and an appropriate  dilution  of affinity-purified rabbit 
anti-isotype  antibodies  were  added.  After  fixation  in  0.0025%  glutaraldehyde,  serial 
dilutions of serum from normal or LP-BM5-infected mice were assayed for their ability 
to inhibit  the  binding of lZSI-labelled  monoclonal antibodies  (mAb) of the appropriate 
isotype.  Standard  inhibition  curves  were  constructed  by  competitive  binding  of l~SI- 
labeled proteins against the same, unlabelled  Ig. 50%  inhibition  of binding was seen at 
0.2-0.6 ug/mi of reference Ig. 
Flow Cytometry Analysis.  Cell  size  and  immunofluorescence  were  analyzed  using  a 
Becton-Dickinson FACS II (fluorescence-activated cell sorter).  Blast cells were defined as 
those with a forward light scatter signal above channel 650, when the unimodal peak of 
small lymphocytes was at channel 400, the amplifier gain at 4, and the argon laser output 
at 400 mW.  Fluorescein emission was excited at 488 nm and collected at 520-530 nm. 
Fluorescent signals were logarithmically amplified before analysis. The percentage of cells 
in  replicative  cycle  was  estimated  by  staining  of ethanol-fixed  cell  suspensions  with 
chromamycin A3 (13). 
Cell Separation.  In some experiments, T  lymphocytes were depleted by treatment with 
anti-Thy-1  mAb  (clone  13-4)  (14)  and  anti-Ly-2  mAb  (clone  3.168)  (15)  followed by 
complement-mediated lysis using rabbit low-Tox M (Accurate Chemical Company, West- 
bury,  NY).  Spleen  cells  were  size-fractionated  by passage over a  discontinuous  Percoll 
gradient (15) for the type of experiment illustrated in Table III. 
Results 
Phenotypic  Changes  in  Lymphoid  and  Nonlymphoid  Cells  Induced  by  LP-BM5 
MuLV.  Injection  of the  LP-BM5  virus  mixture  into  adult  C57BL/6  mice  re- 
sulted in the rapid and reproducible appearance of gross spleen and lymph node 
enlargement.  We examined the cellular composition of these enlarged lymphoid 
organs using mAb against lineage-specific determinants  (17). The results of such 
studies  on spleen  cell populations are summarized  in Tables  I  and  II. Within  1 
wk of LP-BM5  injection,  the number  of spleen  cells almost doubled.  As shown 
TABLE  I 
Changes in C57BL/6 Splenic Lymphocyte Populations lnduced by LP-BM5 MuLV 
"l"ime postinfec-  Blast  cells*  Propor-  tion  (x 10  -6)  tion of  Median cell  T cells  Thy-1  +  B cells 
blast cells  size*  (x 10  -6)  cells  (x 10  -~)  sIg  + cells 
wk  %  %  % 
l  59_+5  ~  29-3  332_+7  47+4  23 "4"3  120+ 10  59-2 
2  96+ 16  36+3  343_9  59-  10  22-7  165 --4- 28  62_+ 1 
3  105+7  39_+4  353_+12  35_+3  13_+4  153_+11  57_+3 
4  136 _+ 26  41 _+ 4  396 -4- 6  43 + 8  13 _+ 4  176 + 34  53 _+ 5 
Control values  34 _  3  29 + 3  325 __ 13  40 ± 4  34 _+ 2  62 + 6  53 -  5 
* Blast cell number measured by increase in light-scatter signal on FACS. 
* Median channel number of light-scatter  signal on FACS. Increasing numbers indicate  increasing 
volume of blast cells. 
Underlined values are significantly different from controls at P < 0.05. M
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in Table I, this increase was mainly due to an increase in the number of surface 
lg-positive  (sIg  +)  B  lymphocytes. The  number  of T  cells  did  not  increase 
significantly, so  the fractional percentage of T  cells  decreased.  There was  an 
increase  in  blast  cells,  as  measured  by  light  scatter.  These  large  cells  were 
predominately B cells,  but some T  cells and some non-T, non-B cells were also 
included in the blast cell fraction. With increasing time after virus infection, B 
cells  and  blast  cells  continued to  increase  in  number.  Mature  T  and  B  cells 
became a  smaller total fraction of the spleen, as 34%  of the spleen cells  were 
neither  Thy-1 +  nor  sIg  +  by  4  wk  post-infection.  A  more  complete  surface 
phenotype profile of these cells is shown in Table II. 
As the lymphoproliferative disease induced by LP-BM5 MuLV progressed, the 
cell populations involved in the disease became more pleimorphic, and individual 
animals showed unique splenic cellular compositions. The fractional percentage 
of Thy-1 + T  cells varied considerably, but seldom reached normal ranges. There 
was a  significant increase  in  granulocytes (identified by  the  8C5  mAb)  in  all 
infected mice. Mac-1 + cells  increased in number in most mice, but since it has 
been suggested that Mac-1  may be expressed on early B-lineage cells as well as 
macrophages (17),  the identity of the Mac-1 + cells was ambiguous. Many of the 
virus-infected mice had expanded numbers of B-lineage cells,  including Lyb-8  ÷, 
Ly-5 (B220)  ÷, and ThB  + cells,  in excess of sIgM  ÷ B cells. This apparent discrep- 
ancy in the expression of B cell markers is probably due to reduced sIg expression 
concomitant with maintenance of other markers on Ig-secreting immunoblasts. 
This view was supported by the observation of a spontaneous fivefoid increase 
in IgM-secreting cells (see below). The increase in IgG2-bearing cells may be due 
to cytophilic binding to Fc receptors on macrophages or B cells. Some mice have 
a significant increase in Ly-1 + cells compared to Thy-1 + T  cells,  (e.g. mice 398 
and 477 in Table I I). This suggests that the Ly-1 + B cell subpopulation (18) had 
expanded in those animals. Finally, some splenic cells in some mice were untyped 
by our reagents; we do not know their identity. 
Lymph node and peripheral blood lymphocytes were also studied, and showed 
similar changes of T  and B cell populations (data not shown). The ratio of Ly- 
1  +/Ly-2  + cells in peripheral blood from virus-infected mice was not substantially 
different from normal controls, although the percentage of recirculating Thy- 
1  + T  cells was diminished by virus infection. 
The rapid increase in lymphoid mass and the appearance of large numbers of 
blast cells (Table I) could be due to either the stable accumulation of nondividing 
blast cells,  or the continued accretion of cells in cycle. To discriminate between 
these alternatives, spleen cells from normal or LP-BM5-infected mice were tested 
simultaneously for surface markers and DNA content (see  Materials and Meth- 
ods). Spleen cells  were either directly stained with chromamycin A3 (13),  anti- 
Thy-1, or anti-Ig, or they were first size-fractionated on a discontinuous Percoll 
gradient, then stained. Table III shows the results of  a representative experiment. 
There was a threefold increase in the fraction of splenocytes in active cycle after 
LP-BM5  infection.  While  most  of the  normal  splenocytes in  cell  cycle  were 
intermediate- to large-sized, substantial numbers of small-sized cells from virus- 
infected mice were in cell cycle. Note also that most T  and B cells were larger 
(and less dense) than normal following virus infection, and that among small, MOSIER  ET  AL.  771 
TABLE  III 
LP-BM5 MuLV Induces Mitosis in T Lymphocytes, B Lymphocytes and Non-T, Non-B Cells of 
All Size Ranges 
Cells in S or  T  cells in  B cells in 
Size range*  Source  G~/M phase  fraction  fraction 
% 
All cells (unfractionated) 
Large (1.062)  ¢ 
Intermediate (1.074) 
Small (1.086) 
Normal  8.0  35.6  56.8 
LP-BM5-infected  24.4  22.5  45.9 
Normal  11.2  27.3  54.2 
LP-BM5-infected  28.7  29.1  36.3 
Normal  7.7  20.7  69.5 
LP-BM5-infected  30.9  25.1  30.4 
Normal  3.7  64.6  18.4 
LP-BM5-infected  19.4  26.6  8.6 
* Spleen cells from normal C57BL/6 mice or C57BL/6 mice 6 wk post-LP-BM5 infection were size- 
fractionated on discontinuous Percoll gradients and stained with chromamycin A3, anti-Thy-1, or 
anti-lg to determine the percentage of cells in cycle, and the percentage of T  cells and B cells in 
each size fraction. 
* Density of cells collected at Percoll gradient interfaces. 
high-density splenocytes, more cells were in cycle than could be accounted for 
by B lymphocytes. We conclude that LP-BM5 induced widespread lymphoproli- 
ferative disease, and that few, if any, normal lymphoid cells escaped involvement 
in the proliferative process. 
Our data show that fewer mature sIg  + B cells are involved in the lymphopro- 
liferative disease than reported previously (5). One explanation for this discrep- 
ancy is that the profound hypergammaglobulinemia (see below and reference 5) 
leads to acquisition of cytophilic IgM by non-B cells. This hypothesis was tested 
by trypsin "stripping" of sIg and evaluation of sIgM density after 24 h of culture 
to allow sIg reexpression. As shown in  Fig.  1,  untreated spleen cells from LP- 
BM5-infected  mice  had  few  sIgM-  cells.  Instead,  a  population  of cells  with 
normal sIgM density, and a diffuse population with low sIgM density was seen. 
Following trypsin treatment and culture, the population with low sIgM density 
disappeared, for the most part, and only the normal slgM density cells remained. 
Data not shown demonstrated that trypsin treatment effectively removed sIgM 
and sIgD from all  B cells. We have thus scored as B cells only those lympboid 
cells with normal ranges of sIg expression. 
LP-BM5 Infection Rapidly Causes B Cell Polyclonal Activation and Hypergamma- 
globulinemia.  Previous  studies  (5)  demonstrated  that  serum  IgM  and  IgG2a 
levels were elevated by 3  wk after virus inoculation, and that there were only 
modest elevations of other Ig isotypes during the course of the disease (5).  Our 
data (Table IV) confirmed the elevation in serum lgM and the lack of significant 
increase  in  serum  IgA  levels.  IgG3  levels,  which  were  not  examined in  the 
previous study, were also significantly elevated.  In addition,  IgG1  levels were 
increased 1 wk after infection. These results for IgG1 levels contrast with those 
reported previously (5).  The discrepancy between our results and the previous 772  MUR1NE  RETROVIRUS-INDUCED  1MMUNOSUPPRESSION 
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FIGURE  1.  FACS histograms of spleen cells from LP-BM5 MuLV-infected (  ) or normal 
(---)  C57BL/6  mice stained with FITC-conjugated anti-# antibodies. In the top panel is 
shown the slgM density of freshly prepared spleen cells,  while the lower panel displays the 
slgM density following trypsin "stripping" of slg and 24 h of culture to allow resynthesis. Note 
that the low-intensity slgM staining of spleen cells from LP-BMS-infected mice is mainly due 
to reaction with cytophilic IgM. MOSIER ET  AL. 
TABLE IV 
Ig Levels in LP-BM5 MuLV-infected C57BL/6 Mice 
773 
Strain and history of mice  IgM  IgG3  IgG 1  IgA 
Normal C57BL/6 (n =  3) 
LP-BM5-infected C57BL/6 
1 wk postinfection (n =  3) 
2 wk postinfection (n =  3) 
3 wk postinfection (n =  3) 
~g/ml 
350 +  36  485 -  164  192 _  26  87 +  13 
1,554 _  1,070  998 +  39  518 +  136  ND 
1,681  _  379  630 +  157  2,335 +  271  54 +__ 20 
2,310 _  420  1,040 _  197  1,019 +  162  97 +  8 
Concentrations of each  isotype were determined  in  a  competitive  RIA  with an  mAb standard  as 
described in Materials and Methods. Results are mean +SEM. ND, not determined. 
ones may reflect differences in assay techniques (see Materials and Methods), or 
differences in the mice used. 
As a further measure of polyclonai activation, spleen cells for LP-BM5-infected 
mice were examined  for IgM-secreting cells by the protein  A-PFC assay (12). 
Within  1  wk  of infection,  the  number  of IgM-secreting  cells  had  increased 
threefold over normal, and by 3 wk there was a  10-fold increase in IgM-secreting 
cells (data not shown). We conclude that viral infection led to an elevation in all 
Ig classes except IgA (or IgE, which has yet to be measured). 
Immunosuppressive  Effects  of LP-BM5  Infection.  To  determine  whether  the 
lymphoproliferative disease and potyclonal B cell activation induced by LP-BM5 
MuLV  adversely  affected  immune  responses,  the  immunocompetence  of 
C57BL/6 mice that had been infected with this virus mixture was examined in a 
series of in vivo and in vitro assays of immunity. 
The data presented in Table V demonstrate that by 4 wk following LP-BM5 
infection,  C57BL/6  mice  were  profoundly  unresponsive  to  SRBC,  a  T  cell- 
dependent antigen.  At this time,  the spleens of infected mice had  increased in 
size  two-  to  threefold,  and  contained  large  numbers  of IgM-secreting  cells. 
However,  immunization  of the  mice  in  vivo,  or  of their  spleen  cells  in  vitro 
resulted  in  no  SRBC-specific PFC  response.  The  few SRBC-specific PFC  that 
were  seen  in  the  virus-infected  mice  appear  to  be  due  to  polyclonal  B  cell 
activation,  since their numbers were unaffected by SRBC immunization.  It can 
also be seen that a  mixture of normal and virus-infected spleen cells gave an in 
vitro anti-SRBC response intermediate between that seen with either population 
alone. This result suggests that active suppression of responsiveness by T  cells or 
continued  viral  replication  was  unlikely.  This  type of mixing  experiment  was 
extended to responses to mitogens and T-independent antigens (see below), and 
in  no  instance  did  we observe evidence of active  suppression  of the  response 
generated by the normal spleen cell component. 
We next examined  the proliferative  responses of spleen ceils from  LP-BM5- 
infected mice to T  or B cell-specific mitogens.  The  response to PHA, Con A, 
LPS, and anti-~ were suppressed in both spleen and lymph node lymphocytes by 
4  wk  postinfection  (data  not  shown).  The  time  course  of the  onset  of this 
suppression in spleen cells is shown in Fig. 2. The response to all four mitogens 
declined within 2-3 wk of infection. PHA and LPS responses diminished sooner 774  MURINE  RETROVIRUS-INDUCED  IMMUNOSUPPRESSION 
TABLE  V 
Infection of C5 7BL/6 Mice With LP-BM5 MuLV Depresses In Vivo and In Vitro Antibody 
Responses to SRBC 
Mouse cells used 
PFC/10  6 cells  PFC/spleen 
SRBC  IgM  SRBC  IgM 
In vivo 
LP-BM5 MuLV-infected 
C57BL/6 (SRBC-im- 
munized) 
LP-BM5 MuLV-infected 
C57BL/6 (unimmun- 
ized) 
Normal C57BL/6 (SRBC- 
immunized) 
In vitro 
LP-BM5 MuLV-infected 
C57BL/6 (5 X 106) 
Normal C57BL/6 (5 x  106) 
LP-BM5 MuLV-infected 
and normal spleen cells, 
1:1  mixture (5 X 106 total) 
<l  672 _+  13  220 _+ 49  355,000 +  21,850 
<1  795 -+ 51  277 -+ 58  419,000 -+ 10,030 
184+35  413_+23  35,117+4,606  81,500-+9,262 
SRBC PFC/culture* 
0 
440 X 1.03  .¢- 
247 x  1,02  -I- 
* Numbers are the mean +SEM of PFC determined using three mice per group. 
Numbers are the mean _.X_.  SE factor of five replicate cultures containing 5 x  106 cells each. 
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FIGURE 2.  Proliferative responses of spleen cells from LP-BM5  MuLV-infected C57BL/6 
mice were compared to responses  of  age- and sex-matched  controls at weekly intervals following 
virus injection. Cells were stimulated with PHA, Con A, LPS, or goat anti-~,, and uptake of 
[3H]thymidine was determined after  3  d  of culture.  Data  were normalized to  the control 
response for each mitogen for the duration of the experiment. Vertical bars represent the 
standard error of the mean. MOS1ER ET  AL.  775 
than Con A or anti-t~ responses. There was a brief but significant increase in the 
anti-~-stimulated proliferative response of B cells 1 wk after infection with LP- 
BM5.  The anti-# response of lymph node B  cells was still elevated 2  wk after 
infection, while LPS-stimulated mitogenesis diminished to 20% of control values 
(data  not shown).  Thereafter,  the proliferative  responses  of lymph node cells 
declined in parallel with splenic responses. 
In the same experiment, we examined the in vitro antibody response of spleen 
cells from  normal or virus-infected mice to the T-independent antigens TNP- 
LPS, TNP-B. abortus, and TNP-FicoI1. By 2 wk after virus infection, the response 
to all three antigens was totally absent.  However, as shown in Table VI, there 
was a  temporary elevation of PFC responses to TNP-B.  abortus and TNP-Ficoll 
1  wk  after  virus  inoculation.  These  increases  were  more  apparent  than  real, 
however, since it is clear that a large number of both TNP-specific and polyclonal 
IgM  PFC  were  generated  independently of antigen addition.  The  polyclonal 
activation induced by LP-BM5, thus, seems to initially augment antigen-driven 
itnnlune responses, and then rapidly preempt or suppress them. 
To further investigate the unresponsiveness of spleen cells from virus-infected 
mice, we studied the survival of IgM-secreting cells and total B cells in culture, 
following exposure to LPS. Serum-free medium (9) was used for this experiment 
rather than FCS-supplemented RPMI  1640,  so that the only stimulus to B cells 
was the added LPS.  Fig.  3, A and B  show that the (initially higher) number of 
IgM-secreting splenic B cells in T  cell-depleted cultures from virus-infected mice 
declined rapidly, with no response to LPS.  By comparison, normal T-depleted 
spleen cells responded to LPS with a  burst of IgM-secreting PFC.  Total B cell 
survival (Fig. 3A) was similar between virus-infected and control groups for the 
first 2 d  of culture, but thereafter, normal B cells increased in number, while B 
cells from virus-infected mice remained nearly constant in number. The failure 
of B lymphocytes from LP-BM5-infected mice to respond to mitogens or antigens 
in culture is, therefore, apparently not due to their inability to survive in short 
term  culture,  but  instead  must  be  related  to  some  intrinsic  defect  in  B  cell 
activation induced by the virus.  In  contrast  to the  results of these short  term 
TABLE  VI 
Antibody  Responses In Vitro Are Elevated 1 wk After LP-BM5 MuLV 
Infection 
PFC/106 cells 
Antigen  Normal spleen  LP-BMS-infected 
spleen 
TNP  IgM  TNP  IgM 
--  0  4,500  70*  11,200 
TNP-LPS  108  10,100  124  12,800 
TNP-B. abortus  82  6,100  158  7,100 
TNP-Ficoll  150  4,600  274  11,000 
I 
* Underlined values  are significantly  greater than corresponding control groups. 
PFC assays  were performed after 4 d of culture, and numbers are the geometric 
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FIGURE 3.  The survival (A) and IgM PFC response (B) of splenic B lymphocytes from LP- 
BM5-infected  (A  A) or normal (O- - -O) C57BL/6 mice stimulated with LPS and cultured 
for 4 d in serum-free Iscove's/F12 medium. IgM-secreting ceils were detected by the protein 
A-PFC assay (12). PFC numbers are per  106 cells initially cultured.  Standard errors (not 
shown) were < 10% of the mean. 
experiments, B lymphocytes from virus-infected mice do not survive well in long- 
term culture (see below). 
In further studies, spleen or lymph node cells from C57BL/6 mice (infected 6 
wk  previously with  LP-BM5  MuLV)  were  stimulated  in  a  one-way MLR  with 
allogeneic BALB/c spleen cells,  or with syngeneic spleen cells from normal or 
virus-infected mice. We also compared the ability of normal and virus-infected 
C57BL/6 spleen cells to stimulate MLR by BALB/c spleen cells. The results of 
one such experiment are shown in Table  VII.  Spleen cells from virus-infected 
mice were unresponsive in  the  MLR,  while lymph node cells generated a  very 
meager response. In addition, the ability of irradiated spleen cells from LP-BM5- 
infected mice to function as stimulators for an MLR by BALB/c spleen cells was 
diminished by ~50%.  In additional studies (not shown), we examined the ability 
of spleen cells from LP-BM5-infected mice to respond in MLR at 2, 3, and 4 wk 
postinfection. We found modest elevation of MLR in some mice at 2  wk after 
viral infection, but all mice showed decreased MLR by 3 wk, and no detectable 
MLR by 4 wk postinfection. 
The ability of spleen cells to generate CTL in MLR was also studied.  Spleen 
cells  from  normal  C57BL/6  mice  or  C57BL/6  mice  infected  with  LP-BM5 MOSIER  ET  AL. 
TABLE  VII 
LP-BM5 MuL V Infection Depresses AUogeneic-MLR 
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Stimulator cells  [SH]Thymidine  Responder cells  (given  1,500 rad)  incorporation* 
Normal C57BL/6 spleen (H-2  b) 
LP-BM5-infected C57BL/6 spleen 
LP-BM5-infected C57BL/6 lymph node 
Normal BALB/spleen (H-2  d) 
cpm × I0 -~ 
C57BL/6 spleen (H-2  b)  13.8 
LP-BM5-infected C57BL/6  4.8 
spleen (H-2  b) 
BALB/c spleen (H-2  d)  94.7 
C57BL/6 spleen (H-2  b)  1.6 
LP-BM5-infected C57BL]6  2.0 
spleen (H-2  b) 
BALB/c spleen (H-2  d)  2.0 
C57BL/6 spleen (H-2  b)  2.1 
LP-BM 5-infected C57BL/6  1.1 
spleen (H-2  b) 
BALB/c spleen (H-2  d)  7.1 
C57BL/6 spleen (H-2  b)  37.5 
LP-BM5-infected C57BL/6  19.9 
spleen (H-2  b) 
BALB/c spleen (H-2  d)  4.9 
CsH spleen (H-2  k)  43.0 
* [SH]Thymidine incorporation following  a 4-h pulse on the fifth day of culture. Standard errors 
(not shown) were +20% of the mean. 
TABLE  VIII 
CTL Activity of LP-BM5 MuLV-infected  C57BL/6 (H-2 b) Spleen 
Cells After In Vitro Stimulation With BALB/c (H-2 a) Cells 
Time postinfec-  CTL activity* against target cells 
tion  H.2  d  H.2 k  H.2  b 
wk 
3  1,092 +  323  101 4- 46  7 4- 7 
7  29*  0  0 
16  8  0  0 
Normal  545 4- 257  34 4- 25  0 
* In CTL lytic units, calculated as described in 10. 
* Only one of three mice gave a weak CTL response. 
MuLV  3,  7,  or  16  wk  previously  were  stimulated  for  5  d  in  culture  with  H-2 d 
BALB/c  cells.  The  recovered  cells  were  assayed  for  their  ability  to  lyse  51Cr- 
labeled  Con  A-induced  blasts of H-2 d,  H-2 k, or  H-2 b origin.  Assays were  set up 
at  multiple  effector/target  ratios,  and  the  net  CTL  activity  calculated  as previ- 
ously  described  (10).  At  3  wk  postinfection,  there  was  an  elevation  of  CTL 
activity (Table  VIII), followed  by a  virtual  disappearance  of CTL  activity  7  wk 
after LP-BM5 infection.  The  elevated CTL  activity early after infection was also 
manifested  as  enhanced  crossreactive  killing  of  H-2 k  targets  following  H-2 d 
stimulation. 
Taken  together,  these  results  show  that  T  cell  function  is  rapidly  impaired 
following  LP-BM5  MuLV  infection,  and  that  T  cell  mitogen  responses  are  lost 778  MUR1NE RETROVIRUS-INDUCED 1MMUNOSUPPRESSION 
before MLR, and MLR before CTL responses. As with some B cell responses, it 
also appears that the virus mixture can temporarily elevate some T  cell responses 
early in the course of the lymphoproliferative disease. 
Mechanisms  of Immunosuppression  in  LP-BM5-induced  Lymphoproliferative  Dis- 
ease.  Injection  of the  LP-BM5  MuLV  mixture  induces  expansion  of the  B 
lymphocyte lineage, T  cell blast formation, and profound suppression of humoral 
and cellular immunity. One possible explanation for the ablation  of T  and  B 
lymphocyte function is that the LP-BM5 virus mixture is directly immunosup- 
pressive.  For example,  the pl5E  viral  envelope protein  of several  mammalian 
retroviruses has been reported to suppress in vitro lymphocyte function (19-22). 
Such a direct immunosuppressive mechanism seems unlikely, since a mixture of 
normal and virus-infected spleen cells should have contained replicating virus 
(R. Yetter and H. C. Morse, unpublished observations), yet the expected response 
of the normal spleen cell component was unimpaired (Table VI). We nonetheless 
chose to address this question directly by adding virus-containing culture super- 
natants to normal C57BL/6 spleen cells. As shown in Table IX, there was only 
marginal suppression  of B cell proliferative responses to LPS and anti-/z at the 
highest concentration of virus, and no suppression of T  cell mitogenesis. Virus- 
containing supernatants failed to suppress in vitro PFC responses to SRBC, TNP- 
LPS, TNP-B. abortus, or TNP-Ficoll (data not shown). It thus seems unlikely that 
the  LP-BM5  MuLV  mixture  is  directly  immunosuppressive  for  T  or  B  cell 
function during short term in vitro experiments. 
An alternative explanation for the immunosuppressive effects of LP-BM5  is 
that the viral infection leads to the generation of activated suppressor T  cells. In 
an attempt to rule out T  cell-mediated suppression, we eliminated T  cells from 
LP-BM5-infected spleen cells by two rounds of treatment with anti-Thy-1  plus 
anti-Ly-2 plus complement, to see if the remaining B cells recovered function. 
These T-depleted spleen cells still were unable to respond to B cell mitogens or 
T-independent antigens (data not shown), so lack of B cell function is unlikely to 
be due to T  suppressor activity. 
TABLE IX 
Addition of LP-BM5 MuLV Directly to Normal C57BL/6 Spleen Cells In Vitro Does Not 
Induce Immunosuppression 
Treatment of  [3H]Thymidine  incorporation in response to mitogen* 
C57BL/6 spleen cells  0  LPS  anti-#  PHA  Con A 
cpm × I0 -s 
controlmedium  11.8+  x 1.16  186.6+  x 1.03  68.7+  x  1.03  211.4+  X. 1.01  264.2 ..  x_ 1.03 
(virus cleared) 
50% LP-BM5  8.4 +x 1.05  169.7  ~ 1.02  57.0  +x 1.02  226.5  +x 1.03  276.5  ~ 1.03 
supernatant 
25%LP-BM5  9.2x+ 1.04  174.2+X_  1.06  64.6~ 1.04  178.9+X  1.13  256.4+X 1.01 
supernatant 
12.5% LP-BM5  10.0+  x 1.06  180.4+  x  1.05  47.7 ..  x  _ 1.08  202.4+  x 1.11  277.7+  x 1.01 
supernatant 
[" H]Thymidine incorporated into DNA following  a 4-h pulse. The geometric mean ~SE factor of 
five replicate cultures is shown. MOSIER  ET  AL.  779 
T  suppressor  cells could  still  have  a  more  limited  role  in  LP-BM5-induced 
immunosuppression in that they might decrease T  helper cell function in virus- 
infected mice. We thus  used nylon wool-passed T  cells from normal  or virus- 
infected mice to supply helper function for T-depleted spleen cells from either 
normal or LP-BM5-infected mice. A representative experiment is shown in Table 
X. T-depleted spleen cells (B cells plus macrophages) were prepared from normal 
C57BL/6 mice, and C57BL/6 mice 6 wk postinfection, as noted above. Nylon 
wool-passed spleen  cells were  used as a  source of T  cells,  but  note  that  the 
recovery of T  cells from spleens of LP-BM5-infected mice was substantially less 
than that from normal spleens. Two points emerged from this experiment. First, 
normal T  cells were unable to reconstitute either the SRBC-specific response or 
the polyclonal response of LP-BM5-infected B cells and  macrophages.  Second, 
the  small  number  of nylon  wool-passed T  cells recovered from virus-infected 
mice, when  mixed with normal T-depleted spleen cells, yielded meager helper 
activity  for  the  SRBC  response,  but  did  support  an  elevated  polycional  IgM 
response (1,407 vs. 690 IgM PFC per  106 cells). These studies thus show that B 
cells from  LP-BM5-infected mice are unresponsive to normal  T  cell-inductive 
signals. In addition, there is the suggestion that some T  cells from virus-infected 
mice  have  an  enhanced  capacity  for  the  polyclonai  activation  of  normal  B 
lymphocytes. 
In a final attempt to demonstrate the extent of virus-induced immunoincom- 
petence, we added exogenous IL-2-containing medium to determine if it could 
reverse the functional defects induced by LP-BM5 infection. As shown in Table 
XI, the addition of IL-2-containing Con A supernatant from normal spleen cells 
failed to restore the proliferative response of spleen cells from LP-BM5-infected 
mice  to  T  or  B  cell  mitogens.  In  similar  experiments  (not  shown),  Con  A 
supernatants  were unable to restore in vitro PFC responses of LP-BM5 spleen 
cells.  Thus,  immunosuppression  induced  by the  LP-BM5 virus mixture  is not 
readily reversible. 
LP-BM5  MuLV Infection  Does  Not  Lead  to  Immortalized  B  Lymphocytes.  We 
TABLE  X 
LP-BM5 MuL V Infection Makes B Cells Unresponsive to Normal 
T Cell Help 
Source of B cells and  PFC* against  macrophages 
Source of T  cells~ 
LP-BM5-in- 
Normal mice  fected mice 
Normal mice  SRBC  78  12 
lgM  690  1,407  I 
LP-BM5-infected  SRBC  0  0 
IgM  40  25 
* Numbers  are  PFC/106  B  cells and  macrophages,  and  represent  the 
geometric mean of five replicate cultures per group. 
* 2  ×  106 nylon wool-passed T  cells were added to 5  ×  106 T-depleted 
spleen cells (B cells plus macrophages) and SRBC- and IgM-specific PFC 
determined after 4 d of culture. 
0 Mean is significantly higher than corresponding group with normal T 
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TABLE  XI 
Interleukin 2 (IL-2)-containing  Con A Supernatant Fails to Reverse Immunosuppression  in 
LP-BM5 MuLV-infected C57BL/6 Mice 
Ceils 
Con A 
superna- 
tant* 
[SH}Thymidine incorporation in response to mitogen* 
0  PHA  Con A  LPS 
cpm  ×  I0 -s 
LP-BM5-infected  -  1.2+  x. 1.13  1.6+  x  1.09  3.3+  x. 1.05  11.8 :_  x. 1.03 
spleen 
+  3,0 +x 1.05  3.0 +X 1.07  5.0 +X 1,03  5.1  +x 1.19 
Normal spleen  -  4,2 x  1.I 7  104,3 +X t,09  128,0 +x 1.06  122.4 +x 1.06 
+  7.2 +x 1.15  107,7 +X 1.05  132.2 x  1,03  58.9 .._X. 1.i0 
* Con A supernatant  was shown to contain 1L-2 by its ability to support the proliferation of the IL- 
2-dependent HT-2 line. Con A supernatant was added up to 50% in this experiment. Residual Con 
A activity was blocked by the addition of 20 mM a-methylmannoside. 
* [aH]Thymidine incorporation expressed as geometric mean X SE. 
isolated spleen cells, lymph node cells,  and bone marrow cells from LP-BM5- 
infected C57BL/6 mice and placed them in tissue culture under a wide variety 
of culture conditions. In no case did mature sIg  + B lymphocytes survive for more 
than 7-8  d.  In contrast, normal C57BL/6 B lymphocytes were able to survive 
for up to 6  wk in culture. Only the bone marrow cultures became established 
lines; these lines were identical to the ones previously established (2) in that they 
contained a predominant stromal cell component and continued to replicate LP- 
BM5 MuLV. We also added LP-BM5 directly to long-term cultures established 
from normal lymphoid tissue. The addition of LP-BM5 was without effect on 
spleen and lymph node cultures, but normal bone marrow could be infected in 
vitro with  LP-BM5  to  yield lines  that  were  morphologically indistinguishable 
from in vivo-derived bone marrow lines, and which continued to replicate virus. 
LP-BM5  MuLV, then,  does not  lead to the immortalization of any lymphoid 
cells, and its role in promoting the survival of bone marrow stromal cell elements 
is obscure. 
Discussion 
The disease induced by the injection of the LP-BM5 mixture of ecotropic and 
MCF MuLV into adult C57BL/6 mice has several features which make it unique 
among retroviral infections of mice. First, the LP-BM5 MuLV-induced disease 
seems clearly to be a lymphoproliferative  process, as first postulated by Pattengale 
et al. (5),  and not a  malignant B celt  lymphoma. There was no evidence from 
our studies or from the earlier studies that B cells  from LP-BM5-infected mice 
were transformed for malignant growth in vitro or in vivo. We have provided 
direct evidence (Table III) for the expansion of lymphocytes, macrophages, and 
myeloid elements during the course of the disease, and we have shown that both 
T  and, to a greater extent, B lymphocytes are actively proliferating, so that the 
lymphoproliferative nature of the disease is thus confirmed. A  second unique 
feature was that adult mice were susceptible to the lymphoproliferative disease; MOS1ER  ET  AL.  781 
neonatal injection of MuLV was not required for disease induction. Third, major 
manifestations of the disease process, namely lymphoproliferation and immuno- 
suppression,  began  with  virtually  no  latency  period.  Fourth,  the  degree  of 
immunosuppression  was  remarkable for a  MuLV  infection, with  virtually no 
immune function detectable by  4  wk  postinfection.  Fifth,  the  mechanism of 
immunosuppression may be unique, particularly within the B cell lineage, where 
most cells were involved in a polyclonal activation process with eventual matura- 
tion  to  antibody-secreting plasmablasts.  Finally,  the  mechanism  of immuno- 
suppression  may depend upon  a  T  ceil-dependent pathway of B  lymphocyte 
activation, since C57BL/6  nu/nu mice developed a  much-attentuated form of 
the disease, with a longer latency period, increased IgM but not IgG levels, and 
preservation of some normal B cell functions (D. E. Mosier, unpublished obser- 
vations). 
The major novel observations we present here relate to the rapid onset and 
profound consequences of LP-BM5-induced immunosuppression. We have dem- 
onstrated a  rapid loss  of T  lymphocyte blastogenic responses to mitogens and 
alloantigens, a somewhat delayed loss (following an initial increase) in cytotoxic 
T  cell generation, and a loss of helper T  cell function for antibody production 
in vitro. There is a concomitant loss of B lymphocyte function, with diminished 
proliferative  responses  to  B  cell  mitogens,  and  inability  to  generate  specific 
antibody responses to T-dependent or T-independent antigens. We found no 
evidence that the LP-BM5  MuLV mixture was directly immunosuppressive in 
vitro (Table  X),  nor was there any suggestion  that  T  suppressor activity was 
enhanced by virus infection. In  view of the evidence that most or all  mature 
lymphocytes are involved in the LP-BM5-induced lymphoproliferative process, 
the simplest explanation  for the profound immunosuppression is that  specific 
immune  responses  are  preempted  by  polyclonal  lymphocyte activation.  The 
preliminary experiments in  C57BL/6  nu/nu mice cited above suggested that 
functional T cells were required for the full development of the LP-BM5-induced 
disease, so the polyclonal activation of B lymphocytes may represent a collabo- 
rative process between T  and B cells. 
The virus mixture that induces this immunosuppressive lymphoproliferative 
disease (which we have renamed the LP-BM5 isolate, but which was referred to 
as RCN-BM5  in previous publications) was derived from bone marrow stromal 
cell cultures established by Haas and Meshorer (2) from virus-inoculated C57BL/6 
mice. The  in  vivo-passaged  MuLV  used to  inoculate the donor  of the bone 
marrow cell line was a  splenic cell-free extract of the viral agent described by 
Laterjet and Duplan (1).  This viral agent was originally derived from C57BL/6 
mice that had received fractionated, low-dose irradiation (23), but it was unique 
in that it caused RCN instead of the more common thymic iymphomas. It has 
been reported (3) that both the LP-MB5 MuLV mixture and a biologically cloned 
dualtropic MuLV  [termed M(BC4)]  could induce lymphoproliferative disease, 
but it now seems likely that the ecotropic/MCF MuLV mixture is required for 
disease induction (M. Haas, personal communications, and R. A. Yetter and H. 
C. Morse, unpublished observations). While much work remains to be done on 
the interaction of MuLV during the induction of this lymphoproliferative disease, 
it may be extremely important for understanding murine or human disease to 782  MURINE  RETROVIRUS-INDUCED  IMMUNOSUPPRESSION 
realize that ongoing interactions among retroviruses may increase their immu- 
nosuppressive and lymphoproliferative effects. 
Several recent studies (19-22,  24)  have suggested that  retroviral structural 
components (particularly pl5E) may be directly immunosuppressive. Since LP- 
BM5  appears  not  to  be  directly immunosuppressive in  vitro,  pl5E-mediated 
suppression seems unlikely. It should also be emphasized that  the degree and 
rapidity of onset of the immunosuppression induced in  mice by the  LP-BM5 
MuLV mixture is much more striking than that induced by Friend, Moioney, or 
Rauscher MuLV (25, 26), where pl5E is thought to play an active role (24). 
The  iymphoproliferative disease  induced by  LP-BM5  MuLV  resembles,  in 
some respects, two human disease states. The first is the X-linked lymphoprolif- 
erative syndrome described by Purtilo et al. (27). This disease appears to be the 
result of Epstein-Barr virus infection of genetically immunodeficient individuals, 
who then develop a fatal expansion of polyclonally activated B lymphocytes. The 
histopathological  features of this  disease are  similar to  the  LP-BM5  MuLV- 
induced disease, but the biology of LP-BM5 infection differs, in that an immu- 
nosuppressive virus infects a normal host, as opposed to an already immunocom- 
promised host. The second human disease which the lymphoproliferative state 
induced by the LP-BM5  MuLV  mixture resembles is  the early phases  of the 
acquired immunodeficiency syndrome (AIDS) when lymphadenopathy (28), hy- 
pergammaglobulinemia,  and  polyclonal  B  cell  activation  (29)  are  prominent 
features.  Despite  the  profound  immunosuppression  associated  with  LP-BM5 
infection, most mice die of respiratory failure due to mediastinal lymph node 
enlargement, and not of intercurrent infections. Perhaps the latter stages of LP- 
BM5 induced disease would more resemble AIDS if the mice were exposed to 
the range of pathogens associated with the human population at risk for AIDS. 
Despite this divergence in the clinical course between AIDS and LP-BM5-induced 
lymphoproliferation, the early similarities in the two diseases and the common 
retroviral etiology suggest that a  further understanding of the biology of the 
murine disease will be enlightening. 
Summary 
We have shown that a mixture of murine leukemia viruses (MuLV) causes the 
acute onset of lymphoproliferation and immunosuppression when injected into 
adult C57BL/6 mice. The ecotropic/MCF (mink cell focus-inducing) mixture of 
MuLV stimulates polycional B lymphocyte proliferation and differentiation to 
antibody-secreting cells. Serum Ig levels are elevated for all isotypes except IgA. 
The viral infection leads to a rapid decline in T lymphocyte responses to mitogens 
and ailoantigens, as well as a  decrease in helper cell activity. Specific antibody 
responses to both T-dependent and T-independent antigens are impaired, and 
the response of B lymphocytes to mitogens is abolished. The profound immu- 
nosuppression  seems to be due to the MuLV-induced polyclonal activation of 
lymphocytes. No  active suppression  of normal  lymphocyte responses  by cells 
from virus-infected mice was  observed.  The  disease induced by the  LP-BM5 
MuLV  isolate  thus  seems  a  promising  model  for  the  study  of  lymphocyte 
activation and the mechanisms of retrovirus-induced immunosupppression. MOSIER  ET  AL.  783 
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